Skip to main content
    V

    Verastem Inc (VSTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.41
    -0.97 (-10.34%)

    Market Cap: $1.14B

    Last updated: Nov 06, 2026 at 4:29 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(18/40)
    Avg Surprise
    -7.71%

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.45
    Range$-0.45 - $-0.45
    1 analysts
    Revenue Consensus
    $41M
    Range$24M - $55M
    9 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.45$-0.45 - $-0.45--1--
    Sep 26
    Reported Nov 5
    		$-0.74$-0.44$-0.44 - $-0.44-68.18%Miss2
    0
    1
    30d
    		-37.0%
    Jun 26
    Reported Aug 6
    		$-0.35$-0.46$-0.46 - $-0.45+23.91%Beat3
    1
    0
    30d
    		+10.3%
    Mar 26
    Reported May 7
    		$-0.43$-0.47$-0.50 - $-0.44+8.51%Beat3
    1
    0
    30d
    		+45.6%
    Dec 25
    Reported Mar 4
    		$-0.46$-0.50$-0.51 - $-0.47+7.55%Beat3
    1
    0
    30d
    		+23.5%
    Sep 25
    Reported Nov 4
    		$-0.54$-0.61$-0.68 - $-0.56+11.48%Beat3
    1
    0
    30d
    		+38.6%
    Jun 25
    Reported Aug 7
    		$-0.39$-0.59$-0.71 - $-0.46+33.90%Beat2
    No revisions (30d)
    		+36.1%
    Mar 25
    Reported May 13
    		$-0.79$-0.77$-0.94 - $-0.61-2.60%Miss2
    1
    0
    30d
    		+19.4%
    Dec 24
    Reported Mar 20
    		$-0.60$-0.74$-0.92 - $-0.53+18.56%Beat3
    0
    1
    30d
    		+41.2%
    Sep 24
    Reported Nov 6
    		$-0.88$-0.82$-1.08 - $-0.65-7.32%Miss9
    No revisions (30d)
    		-23.9%
    Jun 24
    Reported Aug 8
    		$-0.61$-1.06$-1.11 - $-0.65+42.45%Beat7
    1
    0
    30d
    		+47.0%
    Mar 24
    Reported May 9
    		$-0.98$-0.87$-1.19 - $-0.87-12.64%Miss5
    No revisions (30d)
    		+14.0%
    Dec 23
    Reported Mar 14
    		$-1.02$-0.62$-0.88 - $0.43-64.52%Miss7
    No revisions (30d)
    		-1175.0%

    Key Metrics

    Valuation
    P/E Ratio-4.25EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-231.60%Operating Margin-81.60%
    ROE-471.20%ROIC-110.39%
    Financial Health
    Debt/Equity11.82xInterest Coverage-132.21x
    Current Ratio1.93xQuick Ratio1.91x
    Trading Statistics
    Beta0.46Avg Volume5.62M
    52-Week High$10.8252-Week Low$3.43

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$9.63
    SMA 20$9.25
    SMA 50$8.38
    SMA 200$6.24
    EMA 10$9.38
    EMA 20$9.20
    EMA 50$8.43
    EMA 200$7.01

    MACD

    Line: 0.33Signal: 0.47Hist: -0.14

    ADX

    ADX: 31.3+DI: 15.2-DI: 26.3

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down32.0
    PSAR$10.25

    Bollinger Bands

    Upper Band$10.85
    Lower Band$7.64
    %B Position3463%(Upper)
    Band Width0.24

    RSI (14-Day)

    Neutral
    42.9

    Momentum Oscillators

    Stoch %K51.4
    Stoch %D66.8
    Williams %R-72.7
    ROC (10d)-16.2%
    Momentum-1.63
    CCI (20d)-98.8
    MFI (14d)54.0

    Volatility Measures

    ATR (14d)$0.70(8.4%)
    StdDev (20d)0.80
    Hist Vol105.7%(High)

    Volume Flow

    VWAP$8.33
    OBV40.0M
    AD Line-40.2M
    CMF (20d)0.036

    Volume Metrics

    Avg Vol (20d)5.9M
    Vol Ratio1.2x
    VWMA (20d)$8.82

    Pivot Points

    R3$10.47
    R2$10.17
    R1$9.77
    Pivot Point$9.47
    S1$9.07
    S2$8.77
    S3$8.37

    Advanced Oscillators

    TSI15.95
    Ultimate Osc47.7
    KST204.39

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$24.01M$40.08M$18.67M$17.54M$11.24M$2.14M$0$-9,976,000$0$10.00M$0$114,000
    Cost of Revenue$3.67M$3.76M$2.77M$2.61M$1.67M$318,000$0$12,000$0$0$0$5,000
    Gross Profit$20.35M$36.32M$15.90M$14.92M$9.57M$1.82M$0$-9,988,000$0$10.00M$0$109,000
    Operating Expenses$95.57M$69.03M$60.80M$56.40M$50.29M$45.58M$44.17M$31.59M$37.03M$28.28M$28.06M$31.14M
    R&D$68.81M$41.34M$38.22M$31.67M$28.99M$24.79M$29.15M$20.81M$24.75M$18.06M$17.71M$22.50M
    SG&A$26.48M$27.41M$22.30M$24.45M$21.01M$20.67M$15.02M$10.78M$12.28M$10.21M$10.35M$8.64M
    Operating Income$-75,224,000$-32,710,000$-44,897,000$-41,476,000$-40,715,000$-43,764,000$-44,174,000$-31,590,000$-37,030,000$-18,277,000$-28,059,000$-31,139,000
    Interest Income$765,000$1.11M$1.30M$1.10M$1.18M$822,000$960,000$968,000$831,000$983,000$1.37M$1.87M
    Interest Expense$212,000$360,000$382,000$415,000$319,000$212,000$2.02M$1.15M$1.15M$1.14M$1.13M$1.12M
    Income Before Tax$-74,723,000$-33,857,000$-36,591,000$-209,471,000$-98,518,000$-25,934,000$-52,063,000$-130,452,000$0$0$0$-27,701,000
    Income Tax Expense$0$816,000$0$0$0$0$0$0$0$0$0$0
    Net Income$-74,723,000$-34,673,000$-36,591,000$-32,916,000$-98,518,000$-25,934,000$-52,103,000$-64,551,000$-23,967,000$-8,256,000$-33,863,000$-27,368,000
    EBITDA$-74,997,000$-34,441,000$-37,346,000$-33,307,000$-99,089,000$-26,417,000$-50,965,000$-69,985,000$-23,442,000$-8,089,000$-28,502,000$-29,282,000
    EBIT$-75,276,000$-34,605,000$-37,506,000$-33,605,000$-99,381,000$-26,544,000$-51,005,000$-70,199,000$-23,650,000$-8,101,000$-28,089,000$-28,450,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VSTM

    VSTM Valuation and Fair Value

    P/E
    -4.2x
    PEG
    -1.9x
    P/B
    84.3x
    See GNG's fair value

    VSTM Profitability: Margins, ROIC and FCF

    Gross margin
    87.2%
    Operating margin
    -81.6%
    Net margin
    -231.6%
    ROIC
    -110.4%
    ROE
    -471.2%
    FCF margin
    -160.4%

    VSTM Competitors

    CompanyTicker
    Vor Biopharma IncVOR
    Iradimed CoIRMD
    Omada Health, Inc. Common StockOMDA
    Integra LifeSciences HoldingsIART
    CareCloud, Inc.CCLDO
    Si-Bone IncSIBN
    Inhibrx Biosciences, Inc.INBX
    CureVac NVCVAC

    Sector: Healthcare

    VSTM Analyst Ratings

    Consensus
    Buy
    Analysts
    10
    Strong Buy
    1
    Buy
    9
    Hold
    0
    Sell
    0
    Strong Sell
    0

    VSTM Bull Case vs Bear Case

    Bull case

    • VSTM beat EPS estimates in 75.0% of its last 8 reported quarters.
    • VSTM grew quarterly revenue 1775.0% year over year.
    • 100.0% of VSTM's analyst ratings are Buy or Strong Buy.

    Bear case

    • VSTM has a -231.6% net profit margin.
    • VSTM has a debt-to-equity ratio of 11.8x.

    VSTM Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    4.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.45

    VSTM Earnings Date

    VSTM reports Mar 2, 2027, after the close. The date is estimated.

    VSTM Earnings Call

    The latest VSTM earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    VSTM ETF Holders

    GNG tracks 9 ETFs that hold VSTM. The largest weights:

    1. State Street SPDR S&P Biotech ETF (XBI), 0.22% of the fund
    2. Fidelity Enhanced Small Cap Core ETF (FESM), 0.10% of the fund
    3. iShares Russell 2000 ETF (IWM), 0.02% of the fund
    4. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.02% of the fund
    5. Vanguard Extended Market Index Fund ETF Shares (VXF), 0.02% of the fund
    Open the ETF Stock Exposure tool for VSTM

    See insider activity

    Frequently Asked Questions About VSTM

    When does VSTM report earnings?

    Verastem Inc (VSTM) is expected to report earnings on Mar 2, 2027.

    Does VSTM pay dividends?

    Verastem Inc (VSTM) does not currently pay a regular dividend.

    What is VSTM's market cap?

    Verastem Inc (VSTM) has a market capitalization of $1.14B with a current stock price of $8.41.

    Related stocks

    Sector: Healthcare

    All stocks starting with V

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In